Issued Patents All Time
Showing 1–13 of 13 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12268783 | Platform drug delivery system utilizing crystal engineering and theanine dissolution | Harry G. Brittain | 2025-04-08 |
| 10376464 | Characterization of the cocrystal products formed by metoprolol and dabigatran bases with L-theanine | Harry G. Brittain | 2019-08-13 |
| 9896411 | Characterization of the cocrystal products formed by metoprolol and dabigatran bases with L-theanine | Harry G. Brittain | 2018-02-20 |
| 9603939 | Platform drug delivery system utilizing crystal engineering and theanine dissolution | Harry G. Brittain | 2017-03-28 |
| 9603938 | Platform drug delivery system utilizing crystal engineering and theanine dissolution | Harry G. Brittain | 2017-03-28 |
| 9603937 | Platform drug delivery system utilizing crystal engineering and theanine dissolution | Harry G. Brittain | 2017-03-28 |
| 9289439 | Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine | Harry G. Brittain | 2016-03-22 |
| 9289440 | Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine | Harry G. Brittain | 2016-03-22 |
| 9289438 | Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine | Harry G. Brittain | 2016-03-22 |
| 8685948 | Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine | Harry G. Brittain | 2014-04-01 |
| 8476250 | Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine | Harry G. Brittain | 2013-07-02 |
| 8304404 | Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine | Harry G. Brittain | 2012-11-06 |
| 8173625 | Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine | Harry G. Brittain | 2012-05-08 |